Daily Sabah logo

Politics
Diplomacy Legislation War On Terror EU Affairs Elections News Analysis
TÜRKİYE
Istanbul Education Investigations Minorities Expat Corner Diaspora
World
Mid-East Europe Americas Asia Pacific Africa Syrian Crisis Islamophobia
Business
Automotive Economy Energy Finance Tourism Tech Defense Transportation News Analysis
Lifestyle
Health Environment Travel Food Fashion Science Religion History Feature Expat Corner
Arts
Cinema Music Events Portrait Reviews Performing Arts
Sports
Football Basketball Motorsports Tennis
Opinion
Columns Op-Ed Reader's Corner Editorial
PHOTO GALLERY
JOBS ABOUT US RSS PRIVACY CONTACT US
© Turkuvaz Haberleşme ve Yayıncılık 2026

Daily Sabah - Latest & Breaking News from Turkey | Istanbul

  • Politics
    • Diplomacy
    • Legislation
    • War On Terror
    • EU Affairs
    • Elections
    • News Analysis
  • TÜRKİYE
    • Istanbul
    • Education
    • Investigations
    • Minorities
    • Expat Corner
    • Diaspora
  • World
    • Mid-East
    • Europe
    • Americas
    • Asia Pacific
    • Africa
    • Syrian Crisis
    • Islamophobia
  • Business
    • Automotive
    • Economy
    • Energy
    • Finance
    • Tourism
    • Tech
    • Defense
    • Transportation
    • News Analysis
  • Lifestyle
    • Health
    • Environment
    • Travel
    • Food
    • Fashion
    • Science
    • Religion
    • History
    • Feature
    • Expat Corner
  • Arts
    • Cinema
    • Music
    • Events
    • Portrait
    • Reviews
    • Performing Arts
  • Sports
    • Football
    • Basketball
    • Motorsports
    • Tennis
  • Gallery
  • Opinion
    • Columns
    • Op-Ed
    • Reader's Corner
    • Editorial
  • TV
showıng 16 results

Sort by

  • Newest first
  • Oldest first

Date range

  • Any Time
  • Past 24 Hours
  • Past 7 Days
  • Past 30 Days

Section

  • all sections
  • Politics
  • Turkey
  • World
  • Business
  • Sports
  • Life
  • Arts
  • Opinion
  • The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. (Reuters File Photo)

    COVID-19 drug may have mutated virus, study says

    Sep 25, 2023
  • Residents wait in line during COVID-19 tests of the entire population in Macau, China, Nov. 1, 2022. (AFP Photo)

    About 600K people put under COVID lockdown around iPhone plant in China

    Nov 02, 2022
  • Passengers wait to board international flights amid the spread of the new omicron COVID-19 variant, at O.R. Tambo International Airport in Johannesburg, South Africa, Nov. 28, 2021. (Reuters File Photo)

    Turkey evacuates citizens, bans flights amid COVID-19 omicron strain

    Nov 28, 2021
  • Professor Alper Şener holds a vial of the Turkovac COVID-19 vaccine, Izmir, Turkey, Nov. 22, 2021. (AA Photo)

    Health Ministry seeks authorization for COVID-19 vaccine Turkovac

    Nov 25, 2021
  • Security personnel guard an entrance to the Wuhan Jinyintan Hospital which a team from the World Health Organization visited in Wuhan in central China's Hubei province on Saturday, Jan. 30, 2021. (AP Photo/)

    WHO experts visit Wuhan hospital that treated 1st COVID-19 cases

    Jan 30, 2021
  • Turkey's Health Minister Fahrettin Koca receives a dose of Sinovac's COVID-19 vaccine at Ankara City Hospital, in Ankara, Turkey, Jan. 13, 2021. (AFP Photo)

    Vaccination drive against coronavirus begins with health care workers in Turkey

    Jan 13, 2021
  • A nurse administers a dose of CoronaVac to a volunteer at a hospital in Istanbul, Turkey, Dec. 21, 2020. (AP Photo)

    Turkey set to receive 'effective' COVID-19 vaccine amid calls for inoculation

    Dec 25, 2020
  • Eli Lilly logo is shown on one of the company's offices in San Diego, California, Sept. 17, 2020. (Reuters Photo)

    Eli Lilly pauses COVID-19 antibody trial over potential safety concern

    Oct 13, 2020
  • Tablets of Avigan, or favipiravir, developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm Holdings Co. are displayed during a photo opportunity at Fujifilm's headquarters in Tokyo, Oct. 22, 2014. (Reuters Photo)

    Avigan cuts COVID-19 recovery time by 19%, Japan trials show

    Sep 23, 2020
  • The COVID-19 drug, TR-C 19, is ready for human trial.

    Turkey's new COVID-19 drug ready for human testing

    May 05, 2020
Prev 1 2 Next
results per page
10 50
  • POLITICS
  • Diplomacy
  • Legislation
  • War On Terror
  • EU Affairs
  • News Analysis
  • TÜRKİYE
  • Istanbul
  • Education
  • Investigations
  • Minorities
  • Diaspora
  • World
  • Mid-East
  • Europe
  • Americas
  • Asia Pacific
  • Africa
  • Syrian Crisis
  • İslamophobia
  • Business
  • Automotive
  • Economy
  • Energy
  • Finance
  • Tourism
  • Tech
  • Defense
  • Transportation
  • News Analysis
  • Lifestyle
  • Health
  • Environment
  • Travel
  • Food
  • Fashion
  • Science
  • Religion
  • History
  • Feature
  • Expat Corner
  • Arts
  • Cinema
  • Music
  • Events
  • Portrait
  • Performing Arts
  • Reviews
  • Sports
  • Football
  • Basketball
  • Motorsports
  • Tennis
  • Opinion
  • Columns
  • Op-Ed
  • Reader's Corner
  • Editorial
  • Photo gallery
  • DS TV
  • Jobs
  • privacy
  • about us
  • contact us
  • RSS
© Turkuvaz Haberleşme ve Yayıncılık 2021